Diagnosis
Economics
Harm/
aetiology
Prognosis
Therapy
|
|
-
Heart failure
- digoxin continuation was cost effective.
-
| Level of evidence 2b |
Expiry Date November
2003 |
-
Heart failure
- enalapril is more cost-effective than hydralazine-isosorbide.
-
| Level of evidence 1b |
Expiry Date November
2003 |
|